Towards a Translatable Model for Studying Therapeutic Efficacy in Alport Syndrome

被引：0
|
作者：
Zhang, Yanling [1 ]
Nghiem, Linda [1 ]
Wang, Hai [1 ]
Thai, Kerri [1 ]
Oliveira, Chiara [1 ]
Gilbert, Richard E. [1 ]
机构：
[1] Unity Hlth Toronto, Toronto, ON, Canada
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2024年 / 35卷 / 10期
关键词：
D O I：
10.1681/ASN.2024e5rj5pgm
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
SA-PO638
引用
收藏
页数：2
相关论文
共 50 条
  • [31] PPARd Agonism Ameliorates Renal Fibrosis in an Alport Syndrome Mouse Model
    Omachi, Kohei
    O'Carroll, Colin
    Miner, Jeffrey H.
    KIDNEY360, 2023, 4 (03): : 341 - 348
  • [32] A model of autosomal recessive Alport syndrome in English cocker spaniel dogs
    Lees, GE
    Helman, RG
    Kashtan, CE
    Michael, AF
    Homco, LD
    Millichamp, NJ
    Ninomiya, Y
    Sado, Y
    Naito, I
    Kim, Y
    KIDNEY INTERNATIONAL, 1998, 54 (03) : 706 - 719
  • [33] Metformin ameliorates progressive nephritis in a mouse model of Alport syndrome.
    Kaseda, S.
    Omachi, K.
    Yokota, T.
    Kuwazuru, J.
    Kamura, M.
    Teramoto, K.
    Kojima, H.
    Suico, M.
    Shuto, T.
    Otsuki, S.
    Kai, H.
    MOLECULAR BIOLOGY OF THE CELL, 2017, 28
  • [34] Improving the mouse model for studying the efficacy of voriconazole
    Graybill, JR
    Najvar, LK
    Gonzalez, GM
    Hernandez, S
    Bocanegra, R
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (06) : 1373 - 1376
  • [35] A PHASE 2/3 STUDY OF THE EFFICACY AND SAFETY OF BARDOXOLONE METHYL IN PATIENTS WITH ALPORT SYNDROME
    Meyer, Colin
    Warnock, David
    Chin, Melanie
    Goldsberry, Angie
    McCullough, Peter
    O'Grady, Megan
    Toto, Robert
    Ward, Keith
    Block, Geoffrey
    Pergola, Pablo
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 : 480 - 480
  • [36] 7,8-dihydroxyflavone exhibits therapeutic efficacy in a mouse model of Rett syndrome
    Johnson, Rebecca A.
    Lam, Maxine
    Punzo, Antonio M.
    Li, Hongda
    Lin, Benjamin R.
    Ye, Keqiang
    Mitchell, Gordon S.
    Chang, Qiang
    JOURNAL OF APPLIED PHYSIOLOGY, 2012, 112 (05) : 704 - 710
  • [37] Therapeutic efficacy of the BKCa channel opener chlorzoxazone in a mouse model of Fragile X syndrome
    Ferraguto, Celeste
    Piquemal-Lagoueillat, Marion
    Lemaire, Valerie
    Moreau, Maite M.
    Trazzi, Stefania
    Uguagliati, Beatrice
    Ciani, Elisabetta
    Bertrand, Sandrine S.
    Louette, Eric
    Bontempi, Bruno
    Pietropaolo, Susanna
    NEUROPSYCHOPHARMACOLOGY, 2024, 49 (13) : 2032 - 2041
  • [38] DEEP INTRONIC VARIANTS IN X-LINKED ALPORT SYNDROME: FROM DETECTION TO THERAPEUTIC HOPES
    Kachmar, Jessica
    Saei, Hassan
    Boisson, Marie
    Arrondel, Christelle
    Cagnard, Nicolas
    Moriniere, Vincent
    Arkoub, Zaina Ait
    Heidet, Laurence
    Hummel, Aurelie
    Knebelmann, Bertrand
    Gribouval, Olivier
    Bole-Feysot, Christine
    Nitschke, Patrick
    Antignac, Corinne
    Dorval, Guillaume
    PEDIATRIC NEPHROLOGY, 2023, 38 : S52 - S52
  • [39] CyclosporinA Derivative as Therapeutic Candidate for Alport Syndrome by Inducing Mutant Type IV Collagen Secretion
    Kuwazuru, Jun
    Suico, Mary Ann
    Omachi, Kohei
    Kojima, Haruka
    Kamura, Misato
    Kaseda, Shota
    Kawahara, Teppei
    Hitora, Yuki
    Kato, Hikaru
    Tsukamoto, Sachiko
    Wada, Mikiyo
    Asano, Toshifumi
    Kotani, Shunsuke
    Nakajima, Makoto
    Misumi, Shogo
    Sannomiya, Yuya
    Horizono, Jun
    Koyama, Yuimi
    Owaki, Aimi
    Shuto, Tsuyoshi
    Kai, Hirofumi
    KIDNEY360, 2023, 4 (07): : 909 - 917
  • [40] Towards an Italian model of therapeutic community
    Vigorelli, Marta
    EUROPEAN JOURNAL OF PSYCHOTHERAPY & COUNSELLING, 2014, 16 (01) : 27 - 35
12345